Demand: Innovative Arthritis Medicine
Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis.
Company is looking to joint-venture, collaborative development or in-licensing of non-prescrition products, on exclusive basis.
For more details please contact Farmavita.Net.
Kynurenic Acid
Our candidate, based on the Kynurenic Acid research, is a molecule with highly protective effects in the gastrointestinal system. The substance is an analogue of the naturally occurring substance(kynurenic acid) with highly protective effects in the gastrointestinal system. The target of the molecule is mainly excitatory receptors. It may also have some influence on MS. In vivo and in vitro tests were performed on male wistarrats, mice and actually on dogs.
I am looking for a Mezlocillin injection formulation for Asia. CPP from the company havign the MA is needed.
Supply of the formulated product is also needed.
Best regards,
Michel Bulliard
Indoco Remedies Limited
Indoco's strong product development capabilities ensure a steady pipeline of products which can be offered for out licensing in the regulated markets. Indoco offers services like API Development, Formulation development; Analytical and Regulatory support and has successfully registered products in US, UK, Slovenia, Australia, South Africa and many more markets.
N-acetylcysteine 1200 mg effervescent tablets
Reference Product:
Name of the product: Fluimucil 600
Name of the company: Zambon Spa
Patent expiry date: N/A
Dossier:
Language: English
Format: EU CTD
We are in need of technology for Epirubicin and doxorubicin. I will be thankful if someone could help.
Regards,
Ankur Garg
Open source systems lure drug developers
The gradual spread of software automation in drug development may be
getting a boost from open source systems. Most e-clinical systems
today--from data capture and storage to trial management and
operations--are proprietary, despite the excellent work that solutions
providers have done to make their products compatible with existing
standards-based and de facto standard industry systems.
DIABETES III & ALZHEIMER’S DISEASE
DIABETES III: A CAUSE OF ALZHEIMER’S DISEASE
INTRODUCTION
Type III diabetes also known as hybrid or double diabetes is a new and dangerous phenomenon. It is found that type III Diabetes affects brain insulin levels, and appears to be one of the major causes of Alzheimer's disease . Insulin receptors in the brain are sensitive to particles known as ADDL's.
Pharma Marketing 2010
Frankfurt, September 30th, 2010
Pharma Marketing 2010 provides a key platform for Europe's pharmaceutical industry stakeholders, such as yourself, to discover how best to tackle the key challenges of a price-sensitive and increasingly competitive and rapidly changing market.While spending power is decreasing across the globe, companies face intensifying pressure to do more with fewer resources.
UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth
The UK prescription pharmaceutical market was valued at $18.1 billion in 2009. Key growth drivers include growing use of chronic high-value innovative treatments driven by a rising elderly population, high public healthcare expenditure as proportion of total healthcare expenditure, relatively light pricing controls through the PPRS, and speedy domestic drug approvals.
- Networking Tips & Tricks
Membership at Farmavita.Net is Free
Register yourself and connect with community of 600+ pharmaceutical executives, researchers and innovators. Expand your professional network and find new business and career development opportunities.
Click here for registration!
- Latest Published
- Site Sections
- Popular Pages
